For four days, from May 12 to 15, the Research Institute of Molecular Pathology (IMP) in Vienna will host the EMBO-Workshop “SMC proteins – Chromosomal organizers from bacteria to human“.
The scientific meeting, jointly organised by the IMP and EMBO (the European Molecular Biology Organization), draws the world’s leading experts on SMC proteins to the IMP at the Vienna Biocenter.
For the first time, the topic will be highlighted to such an extent, with talks and discussions spanning the entire spectrum from pure basic research to future therapeutic concepts for human medicine.
Proteins of the SMC (Structural Maintenance of Chromosomes)-family are one of the most fundamental classes of chromosomal organizers and are found in all organisms, from bacteria to humans. They are involved in a wide variety of chromosomal processes, including cell division, DNA repair and gene regulation.
Just how essential SMC proteins are to all living beings is underpinned by the fact that their mode of action is virtually identical when simple life-forms such as yeast are compared to human cells. (Baker’s yeast is therefore a popular model organism for scientists studying SMC proteins).
Their universality also means that dysfunctional SMC proteins may bear serious consequences: they have been linked to human developmental syndromes and mutations in SMC proteins are frequently seen in certain types of cancer. Life scientists from the fields of structural biology to human genetics are therefore interested in understanding how SMC proteins work and how exactly their failure is linked to human disease.
The first SMC-complexes were identified and described about 20 years ago. Pioneering research was carried out at the IMP in Vienna by Kim Nasmyth, the institute’s director from 1997 to 2006. Together with Doug Koshland in the USA, he discovered the cohesin-complex in the yeast Saccharomyces cerevisiae. Jan-Michael Peters, scientific director of the IMP since 2013, has been studying cohesin in human cells for many years.
This long-standing focus makes the IMP an ideal meeting-point for leading experts in the area of SMC proteins. Openings for the workshop filled up fast and around 140 researchers – from New Zealand to Canada – are expected at the IMP over the next four days.
Among them are Kim Nasmyth (University of Oxford), Doug Koshland (University of California, Berkeley), Mitsuhiro Yanagida (Okinawa Institute of Science and Technology) Frank Uhlmann (Crick Institute, London), Jan Löwe (MRC Lab of Molecular Biology, Cambridge), David Sherratt (Department of Biochemistry, University of Oxford), Barbara Meyer (Berkeley), Yoshinori Watanabe, Katsu Shirahige (Tokyo University), Xiaolan Zhao (Memorial Sloan Kettering Cancer Center, New York), and Tatsuya Hirano (RIKEN Institute, Japan).
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 35 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology. The IMP is a founding member of the Vienna Biocenter, Austria’s flagship location in the global arena of cutting-edge research in molecular biology.
The European Molecular Biology Organization (EMBO) is an organization of more than 1,700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.”
T: +43 1 79730 3627
M: +43 664 80847 3627
T: +43 1 79730 3625
M: +43 664 8247910
Dr. Heidemarie Hurtl | idw - Informationsdienst Wissenschaft
Virtual Worlds: Research Trends in Mobile 3D Data Collection
30.11.2016 | Fraunhofer IPM
4th UKP-Workshop 2017 – Save the Date!
15.09.2016 | Fraunhofer-Institut für Lasertechnik ILT
The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.
Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...
The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...
Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.
Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...
Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...
Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.
A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...
20.04.2017 | Event News
18.04.2017 | Event News
03.04.2017 | Event News
21.04.2017 | Physics and Astronomy
21.04.2017 | Health and Medicine
21.04.2017 | Physics and Astronomy